Literature DB >> 3501091

Quantitative evaluation of ocular anti-inflammatory drugs based on measurements of corneal temperature in rabbits: dexamethasone and glycyrrhizin.

H Tanaka1, T Hasegawa, M Matsushita, H Miichi, S Hayashi.   

Abstract

A method for the quantitative evaluation of topically applied anti-inflammatory agents is described. Conjunctival inflammation was induced in rabbits by topical instillation of n-butanol. The intensity of inflammation was determined by measuring changes of corneal surface temperature with an infrared thermometer. The closest correlation was obtained between corneal temperature change and the Draize score which is widely used as a subjective scoring method. Dexamethasone showed a good logarithmic dose-response inhibitory effect between 0.0001 and 0.1%, and glycyrrhizin the same at 0.25-5%. Glycyrrhizin in a 5% solution showed a comparable anti-inflammatory effect to that of dexamethasone (0.1%). The inflammation model induced by n-butanol was mediated, in part, by the degranulation of mast cells because of some inhibitory effect of disodium cromoglycate (2%), an inhibitor of mast cell degranulation, and diphenhydramine hydrochloride (0.5%), an antihistaminic agent.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3501091     DOI: 10.1159/000265496

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  4 in total

1.  Glycyrrhizin as a promoter of the late signal transduction for interleukin-2 production by splenic lymphocytes.

Authors:  Y H Zhang; K Isobe; F Nagase; T Lwin; M Kato; M Hamaguchi; T Yokochi; I Nakashima
Journal:  Immunology       Date:  1993-08       Impact factor: 7.397

2.  Modulation by glycyrrhetinic acid derivatives of TPA-induced mouse ear oedema.

Authors:  H Inoue; T Mori; S Shibata; Y Koshihara
Journal:  Br J Pharmacol       Date:  1989-01       Impact factor: 8.739

3.  Inhibitory effects of glycyrrhetinic Acid on DNA polymerase and inflammatory activities.

Authors:  Tsukasa Ishida; Yoshiyuki Mizushina; Saori Yagi; Yasuhiro Irino; Shin Nishiumi; Ikuya Miki; Yasuyuki Kondo; Shigeto Mizuno; Hiromi Yoshida; Takeshi Azuma; Masaru Yoshida
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-14       Impact factor: 2.629

4.  Efficacy and safety of glycyrrhizin 2.5% eye drops in the treatment of moderate dry eye disease: results from a prospective, open-label pilot study.

Authors:  Carole Burillon; Frederic Chiambaretta; Pierre-Jean Pisella
Journal:  Clin Ophthalmol       Date:  2018-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.